Focus Partners Wealth’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
Focus Partners Wealth's BBH Position: Q3 2026 in Review
Focus Partners Wealth opened a new position in VanEck Biotech ETF (BBH) in Q3 2026: 936 shares worth $229K. The stake represents ﹤0.01% of the portfolio and ranks #2513 among its holdings. This is a return to the name: Focus Partners Wealth previously reported a position in BBH as recently as Q4 2024.
Focus Partners Wealth first reported a position in BBH in Q1 2024 and has held it in 4 quarters since. The position peaked at $299K in Q2 2024. 122 funds tracked by Wall St. Rank hold BBH as of Q3 2026.
- Focus Partners Wealth held 936 shares of VanEck Biotech ETF worth $229K as of Q3 2026.
- VanEck Biotech ETF was a new Focus Partners Wealth position in Q3 2026.
- VanEck Biotech ETF made up ﹤0.01% of Focus Partners Wealth's portfolio in Q3 2026, its #2513 holding.
- Focus Partners Wealth first reported a position in VanEck Biotech ETF in Q1 2024 and has held it in 4 quarters since.
- Focus Partners Wealth's VanEck Biotech ETF position peaked at $299K in Q2 2024.
- 122 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2026.
Based on Focus Partners Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.